Iqvia Holdings Inc (IQV) Insider Ari Bousbib Sells 46,080 Shares

Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 46,080 shares of Iqvia stock in a transaction on Friday, December 1st. The shares were sold at an average price of $101.79, for a total transaction of $4,690,483.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Ari Bousbib also recently made the following trade(s):

  • On Wednesday, November 1st, Ari Bousbib sold 46,080 shares of Iqvia stock. The shares were sold at an average price of $108.14, for a total value of $4,983,091.20.
  • On Monday, October 2nd, Ari Bousbib sold 46,080 shares of Iqvia stock. The shares were sold at an average price of $94.91, for a total value of $4,373,452.80.

Shares of Iqvia Holdings Inc (NYSE:IQV) traded down $0.27 during trading hours on Wednesday, hitting $101.00. The company had a trading volume of 1,012,100 shares, compared to its average volume of 1,504,491. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. The firm has a market cap of $21,316.11, a P/E ratio of 23.12, a price-to-earnings-growth ratio of 1.66 and a beta of 0.61. Iqvia Holdings Inc has a 1 year low of $74.73 and a 1 year high of $110.67.

Iqvia (NYSE:IQV) last issued its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.05. The firm had revenue of $2.02 billion during the quarter, compared to the consensus estimate of $2.01 billion. Iqvia had a return on equity of 12.60% and a net margin of 0.58%. The company’s quarterly revenue was up 77.6% on a year-over-year basis. During the same period last year, the company earned $1.00 EPS. sell-side analysts expect that Iqvia Holdings Inc will post 4.62 EPS for the current year.

IQV has been the topic of a number of research reports. BidaskClub lowered Iqvia from a “strong-buy” rating to a “buy” rating in a report on Friday, August 11th. Argus raised their price objective on Iqvia from $98.00 to $104.00 and gave the company a “buy” rating in a report on Monday, September 18th. Royal Bank Of Canada initiated coverage on Iqvia in a report on Tuesday, September 19th. They issued an “outperform” rating and a $116.00 price objective on the stock. KeyCorp restated a “buy” rating and issued a $100.00 price objective on shares of Iqvia in a report on Sunday, September 24th. Finally, Robert W. Baird reiterated a “hold” rating and set a $98.00 price target on shares of Iqvia in a report on Monday, October 9th. Nine investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Iqvia has a consensus rating of “Buy” and an average target price of $105.23.

COPYRIGHT VIOLATION NOTICE: “Iqvia Holdings Inc (IQV) Insider Ari Bousbib Sells 46,080 Shares” was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at

Iqvia Company Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Insider Buying and Selling by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia Holdings Inc and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply